FilingIndex
10-KThe Record

Ultragenyx Pharmaceutical Inc. files 10-K

Filed Feb 21, 2018 · 8y ago · Accession 0001564590-18-002535

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
RARE
CIK
1515673
Form type
10-K
Filing date
Feb 21, 2018
Report date
Dec 31, 2017
Document
rare-10k_20171231.htm
Size
21.7 MB